An interventional study of Auricular Acupressure NADA in Breast Cancer Females, sponsored by Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF). Recruiting at 1 site in Germany. Open to female participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 201 studies in Pain with a site in Germany — 13 open to participants now, 14 under way, 8 of them phase 3. Pain · Germany.
Among the 201 studies in Pain with a site in Germany, this one is the 114th largest by planned enrollment of the 162 interventional ones that give a count, is the only one that started in 2026, is one of 58 with no phase, reaches primary completion later than 11 of the 13 other live ones, and was the 201st registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →13 of the 201 studies in Pain with a site in Germany are open now. Recruiting first, the newest first:
Apurano Pharmaceuticals GmbH · Sites in Germany
Ages 18+
Apurano Pharmaceuticals GmbH · Sites in Germany
Ages 18+
Apurano Pharmaceuticals GmbH · Sites in Germany
Ages 18+
Apurano Pharmaceuticals GmbH · Sites in Germany
Ages 18+
Apurano Pharmaceuticals GmbH · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 99 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
201 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 15 · Phase 2 33 · Phase 3 50 · Phase 4 13
First in 2001; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 66 is close to the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 111 across the 162 interventional studies, 100 across the 39 observational. Of the 169 that completed or were terminated, 49 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
95 of 201 have an industry lead sponsor. The 10 most frequent:
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) has 1 study filed under Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Pain with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07423039Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)Auricular Acupressure for Perioperative Anxiety and Pain in Therapeutic Breast Surgery (ROSA) | 2027-06-30 |
| NCT05867186Johannes Gutenberg University MainzFit to Fight Childhood Cancer | 2027-07-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 201 studies in Pain with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This randomized, controlled, single-center trial investigates the effects of auricular acupressure, administered according to the National Acupuncture Detoxification Association (NADA) protocol, on perioperative anxiety and pain in patients with a first diagnosis of breast cancer undergoing therapeutic breast surgery. Participants receiving auricular acupressure according to the NADA protocol will be compared with patients receiving standard care alone.
Participant recruitment is conducted directly through the clinical department Naturopathy and integrative medicine in the Rober-Bosch-Hospital . During routine care, the study physician informs eligible patients about the study and provides the patient information sheet upon initial interest. The physician subsequently conducts a comprehensive informed-consent discussion and addresses all patient questions. Written consent is obtained only after this process. Participation is voluntary and may be withdrawn at any time without consequences for the patient.
Patients will complete validated instruments measuring anxiety and pain. Participants randomized to the intervention group (auriculotherapy) will receive the treatment during their hospitalization and will be compared with a control group receiving standard care.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
This study's planned enrollment of 66 is close to the median of 66 across 8,512 interventional studies indexed under Pain.
Browse Pain studies →Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Compared within Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The intervention group receives ear acupressure according to the NADA protocol.
Other: Auricular Acupressure NADA
The group receives standard preoperative care
"NADA" Auricular Acupressur: The intervention group receives ear acupressure according to the NADA protocol. Before surgery, patients receive Acupressure patches are placed on five specific points on the ear. These patches remain on the skin for five days. Patients are instructed to press or massage the beads in the patch three times a day.
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: Day 0, preoperative
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: Immediately after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: One Day after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: Two Days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: three days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: four days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: five days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: six days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: seven days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: eight days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 20-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: nine days after the operation
Anxiety
The State-Trait Anxiety Inventory (STAI-S) is a 40-item scale used to measure anxiety levels, ranging from 20 to 80. Higher scores are positively correlated with higher anxiety levels.
Time frame: ten days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: Day 0, preoperative
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: Immediately after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: One Day after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: Two days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: three days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: Four days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: five days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: six days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: seven days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: eight days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: nine days after the operation
Pain intensity
Pain intensity is recorded using a numerical rating scale from 0 to 10, where 0 is no pain and 10 is severe pain and and the medication the patient is taking, as recorded in the patient file.
Time frame: ten days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Ten Days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: One Day after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Two days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Three days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: four days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Five days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Six days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Seven days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Eight days after the operation
Nausea and vomiting
PONV stands for postoperative nausea and vomiting, which describes nausea and vomiting after surgery. It is documented on a scale from 0 to 10, where 0 is no nausea and 10 is the most severe nausea imaginable. The use of antiemetics will be registered in the patient file.
Time frame: Nine days after the operation
STAI-T
STAI-T scale is a standardised method of measuring anxiety. This refers to the measurement of trait anxiety. The range of possible scores varies from a minimum of 20 to a maximum of 80, where higher scores represent higher anxiety.
Time frame: Before the operation
Preoperative Anxiety
The APAIS (Amsterdam Preoperative Anxiety and Information Scale) is a questionnaire designed to assess preoperative anxiety and patients' need for information. The questionnaire consists of six questions, divided into two scales: four questions about anxiety related to anesthesia and surgery, and two questions about the need for information. Six questions were answered using a five-point Likert scale ranging from 1 (not anxious at all) to 5 (extremely anxious).
Time frame: Before the operation
Depression
Beck Depression Inventory (BDI) Scores range between 0 and 63, with higher scores representing more severe depression symptoms.
Time frame: Before the operation
Safety evaluation
To assess safety, participants will be asked whether they experienced any adverse events (AEs) during the intervention period. All reported AEs will be documented and classified by type and severity according to the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The outcome will be the number of participants with at least one treatment-related adverse event recorded from baseline throgh the end of the intervention.
Time frame: Ten Days after the operation
Infection
Cases of infection in the surgical area requiring antibiotic treatment will be recorded as either "Yes" or "No". This data will be extracted from the patient's medical records.
Time frame: Ten days after the operation
Postoperative bleeding
Cases of postoperative bleeding will be recorded as either 'yes' or 'no'. This information will be extracted from the patients' medical records.
Time frame: Ten days after the operation
Started Mar 2026 (actual). Primary completion is estimated for Jun 2027, 14 months after the start.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 14 months is above that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)